薬剤発見におけるAI駆動のリバースドッキングの活用:機会,課題,新興傾向の包括的なレビュー
Olanrewaju Ayodeji Durojaye1,2, Sm Faysal Bellah3, Henrietta Onyinye Uzoeto4,5
1Drug Discovery and Biotechnology Unit, Lion Science Park, University of Nigeria, Nsukka, 410001, Nigeria. lanredurojaye@mail.ustc.edu.cn.
Journal of molecular modeling
|August 25, 2025
まとめ
人工知能 (AI) は効率的な薬物発見のために逆ドッキングを強化し,標的の識別と再利用を支援します. このAIによるアプローチは 仮想スクリーニングを最適化し 薬物相互作用を予測し 精密薬の開発を加速します
科学分野:
- コンピュータ化学
- バイオ情報学
- 薬物の発見
背景:
- 逆ドッキングによる人工知能 (AI) の統合は 医薬品開発に革命をもたらします
- リバースドッキングは,薬効性および安全性プロファイルのための潜在的な結合部位を特定します.
- AI技術はターゲット選択,仮想スクリーニング,およびコンフォメーションサンプリングを最適化します.
研究 の 目的:
- 薬剤開発における AI 駆動のリバースドッキングの変革の可能性を 検討する.
- 薬物の再利用や精密医療の応用を強調する
- マルチオミックスのデータ統合を含む将来の見通しについて議論する.
主な方法:
- AIフレームワーク (機械学習,ディープラーニング,強化学習) と統合されたリバースドッキングプラットフォームを使用します.
- ターゲット選択,相互作用予測,高度なサンプリングテクニックを活用する.
- 分子ドッキングソフトウェアでAI最適化された仮想スクリーニングのワークフローを実装します.
主要な成果:
- 人工知能によるリバースドッキングは 薬物の再利用とパーソナライズド医療に 期待を寄せています
- 成功したケーススタディは,この総合的なアプローチの有効性を示しています.
- ハイ・スループット・パイプラインは,マルチ・オミックス・データセットによるデータ統合の課題に取り組んでいます.
結論:
- AI駆動のリバースドッキングは 薬の発見と開発を加速させる強力なツールです
- マルチオミクスデータとリアルタイム・パイプラインとの 将来の統合により パーソナライズド・メディックは 進歩するでしょう
- この方法論は,新しい治療目標と相互作用を特定するための大きな可能性を秘めています.
関連する概念動画
Drug Discovery: Overview
8.7K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
8.7K
Structure-Activity Relationships and Drug Design
1.0K
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
1.0K
Protein-Drug Binding: Mechanism and Kinetics
931
Protein-drug binding refers to the interaction between drugs and proteins within the body. This binding process can occur intracellularly, involving drug interactions with enzymes or receptors within cells, or extracellularly, involving plasma proteins in the blood.
Various forces drive these interactions, including hydrogen bonds, hydrophobic interactions, ionic bonds, electrostatic interactions, and van der Waals forces. These bonds enable drugs to bind to specific sites on proteins,...
Various forces drive these interactions, including hydrogen bonds, hydrophobic interactions, ionic bonds, electrostatic interactions, and van der Waals forces. These bonds enable drugs to bind to specific sites on proteins,...
931
Drug Clearance: Overview
162
Drug elimination refers to drug removal from the body, either through urine or bile, by the kidneys or liver, respectively. A pharmacokinetic parameter, drug clearance, measures the efficiency of drug removal from the bloodstream within a specific time frame. It is calculated as the rate at which a drug is eliminated from plasma divided by the drug's concentration in plasma.
Drug clearance is not limited to renal excretion but encompasses all organs involved in drug elimination, including...
Drug clearance is not limited to renal excretion but encompasses all organs involved in drug elimination, including...
162
Drug Delivery: Overview
422
The selection of a drug's delivery route depends upon its physicochemical properties, including lipid or water solubility and ionization, as well as the therapeutic requirement, such as immediate or sustained effect. These routes can be divided into three primary categories: enteral, parenteral, and topical.
Enteral delivery involves administering drugs directly through swallowing, sublingual placement, or buccal application. Orally administered drugs predominantly navigate the...
Enteral delivery involves administering drugs directly through swallowing, sublingual placement, or buccal application. Orally administered drugs predominantly navigate the...
422


